Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/18/2025

Treatment of Submucosal Fibroids

Definitive Recommendations

  • The American College of Radiology recommends hysteroscopic myomectomy as the procedure of choice for submucosal fibroids <5 cm, offering shorter hospitalization, faster recovery, and equivalent symptom improvement compared to more invasive surgical approaches 1, 2
  • Hysteroscopic myomectomy provides equivalent improvement in symptom scores and quality of life at 2-3 months compared to laparoscopic or open approaches, with significantly shorter hospitalization and faster return to activities 1, 2

Medical Management

  • The American College of Radiology suggests NSAIDs and estrogen-progestin oral contraceptive pills as first-line medical options to reduce bleeding symptoms 1, 3
  • Levonorgestrel-releasing intrauterine devices provide effective long-term bleeding control 3
  • Tranexamic acid is the preferred nonhormonal alternative for patients who cannot or prefer not to use hormonal options 1, 3
  • Oral GnRH antagonists reduce bleeding symptoms and fibroid volume by 18-30% 2, 3
  • Combination hormone add-back therapy with low-dose estrogen and progestin is mandatory to mitigate hypoestrogenic side effects while maintaining efficacy 3

Minimally Invasive Options

  • Uterine Artery Embolization (UAE) improves symptom scores and quality of life for up to 7 years, with a 94% short-term and 85% long-term symptom improvement 3
  • UAE demonstrates superior fibroid diameter reduction (53%) compared to laparoscopic uterine artery occlusion (39%) 3
  • MR-Guided Focused Ultrasound (MRgFUS) has a higher reintervention rate (30%) compared to UAE (13%) 3

Definitive Treatment

  • Hysterectomy provides definitive resolution of all fibroid-related symptoms and accounts for three-quarters of fibroid treatment in the United States 1, 3

Diagnostic Considerations

  • Saline infusion sonohysterography (SIS) shows good agreement (kappa 0.80) with diagnostic hysteroscopy for classifying submucosal fibroids 4
  • SIS accurately depicts the percentage intracavitary component, which has direct treatment implications 4
  • Conventional MRI cannot accurately differentiate fibroids from sarcomas, a critical distinction for surgical planning 4

Special Population Considerations

  • Postmenopausal patients should always undergo endometrial biopsy prior to intervention to rule out endometrial neoplasia and diagnose potential sarcoma 3
  • Pedunculated submucosal fibroids can sometimes be expelled through the cervix, causing acute pain 2

Fertility Considerations

  • Successful pregnancy has been reported after UAE, but comprehensive data on fertility and pregnancy is lacking—patients should be counseled accordingly 1
  • Hysteroscopic myomectomy preserves fertility while definitively treating the fibroid 1

Treatment Hierarchy Summary

  • Hysteroscopic myomectomy is the recommended treatment for submucosal fibroids <5 cm (definitive, uterus-preserving) 1, 2
  • Medical management is recommended for bleeding control or surgical delay (NSAIDs, hormonal contraceptives, tranexamic acid, GnRH agonists/antagonists) 1, 3
  • UAE is recommended for patients desiring uterus preservation who are not surgical candidates or prefer minimally invasive approach 3
  • Hysterectomy is recommended for definitive resolution when childbearing is complete and less invasive options are inadequate 1, 3

REFERENCES

2

Symptoms and Treatment of Submucosal Fibroids [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Uterine Fibroid Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

acr appropriateness criteria® fibroids. [LINK]

Journal of the American College of Radiology, 2022